衰え て いる 人 の 心臓 の 代謝 柔軟 性 を 保つ
William D Watson1,2, Peregrine G Green1,3, Andrew J M Lewis1
1Oxford Centre for Magnetic Resonance Research (W.D.W., P.G.G., A.J.M.L., P.A., L.V., S.N., O.J.R.), University of Oxford, UK.
Circulation
|May 18, 2023
まとめ
心不全の患者は 代謝の柔軟性を維持します グルコースではなく脂肪酸の酸化を促し 心臓のエネルギーと機能を向上させ 現在の治療法に挑戦します
科学分野:
- 心臓病科
- 代謝に関する研究
- 生物化学
背景:
- 衰弱した心臓は 伝統的に代謝的に不柔軟で 酸素不足とみなされ エネルギー不足と収縮能力の低下につながります
- グルコースの酸化を促進する代謝調節剤を標的とした現在の治療法は,一貫していない結果をもたらしました.
研究 の 目的:
- 心臓のメタボリック・フレキシビリティと酸素の供給を,エジェクション・フラクションが低下した心不全の患者で調べる.
- 血糖と脂肪酸の代謝が心臓の機能とエネルギーに及ぼす影響を比較する.
主な方法:
- 20人の非血栓性心不全患者には,インスリン+グルコース (I+G) またはイントラリピドを注入した.
- 心血管磁気共鳴画像,-31磁気共鳴スペクトロスコーピー,侵入性動脈静脈採取を用いた.
- 心臓の機能,エネルギー,基板の利用,および心筋の酸素吸収 (MVo2) を評価した.
主要な成果:
- 衰弱した心臓は 代謝の柔軟性を示し 供給と作業量に 基板の使用を適応させました
- 内脂質注入により,長鎖脂肪酸 (LCFA) の吸収と酸化が増加し,心筋のエネルギーとシストリック/ダイアストリック機能が改善されました.
- 血糖酸化が増加したにもかかわらず,インスリン+グルコース注入は心臓機能を改善しませんでした.
結論:
- 心臓のメタボリック・フレキシビリティは,エジェクション・フラクションが低下した心不全で維持されます.
- LCFAの吸収と酸化の増加は,心臓のエネルギーと収縮性の改善と関連しています.
- 脂肪酸の酸化を促進する戦略は,心不全に対する新しい治療方法を提供することができます.
関連する概念動画
Pathophysiology of Heart Failure
1.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Heart Failure II: Pathophysiology
17
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
17
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure I: Introduction
26
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
26
Pathophysiology of Cardiac Performance
714
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
714
Cardiomyopathy II: Dilated Cardiomyopathy
12
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
12


